BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26015772)

  • 1. IGFBP-3 reduces eNOS and PKCzeta phosphorylation, leading to lowered VEGF levels.
    Zhang Q; Jiang Y; Steinle JJ
    Mol Vis; 2015; 21():604-11. PubMed ID: 26015772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-adrenergic receptor agonist decreases VEGF levels through altered eNOS and PKC signaling in diabetic retina.
    Jiang Y; Zhang Q; Steinle JJ
    Growth Factors; 2015; 33(3):192-9. PubMed ID: 26115368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.
    Jarajapu YP; Cai J; Yan Y; Li Calzi S; Kielczewski JL; Hu P; Shaw LC; Firth SM; Chan-Ling T; Boulton ME; Baxter RC; Grant MB
    PLoS One; 2012; 7(7):e39398. PubMed ID: 22792172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone restores IGFBP-3 levels through DNA PK in retinal endothelial cells cultured in hyperglycemic conditions.
    Thakran S; Zhang Q; Morales-Tirado V; Steinle JJ
    Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):177-84. PubMed ID: 25525174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).
    Kielczewski JL; Li Calzi S; Shaw LC; Cai J; Qi X; Ruan Q; Wu L; Liu L; Hu P; Chan-Ling T; Mames RN; Firth S; Baxter RC; Turowski P; Busik JV; Boulton ME; Grant MB
    Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8278-86. PubMed ID: 21931131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.
    Kielczewski JL; Jarajapu YP; McFarland EL; Cai J; Afzal A; Li Calzi S; Chang KH; Lydic T; Shaw LC; Busik J; Hughes J; Cardounel AJ; Wilson K; Lyons TJ; Boulton ME; Mames RN; Chan-Ling T; Grant MB
    Circ Res; 2009 Oct; 105(9):897-905. PubMed ID: 19762684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor acts through novel, pregnancy-enhanced receptor signalling pathways to stimulate endothelial nitric oxide synthase activity in uterine artery endothelial cells.
    Grummer MA; Sullivan JA; Magness RR; Bird IM
    Biochem J; 2009 Jan; 417(2):501-11. PubMed ID: 18816248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Captopril alleviates oxidative damage in diabetic retinopathy.
    Gao X; Liu K; Hu C; Chen K; Jiang Z
    Life Sci; 2022 Feb; 290():120246. PubMed ID: 34953892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGFBP-3 inhibits TNF-α production and TNFR-2 signaling to protect against retinal endothelial cell apoptosis.
    Zhang Q; Steinle JJ
    Microvasc Res; 2014 Sep; 95():76-81. PubMed ID: 25086184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide.
    Zhang XL; Wen L; Chen YJ; Zhu Y
    Chin Med J (Engl); 2009 Feb; 122(3):338-43. PubMed ID: 19236815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-α-activated eNOS signaling increases leukocyte adhesion through the
    Aguilar G; Córdova F; Koning T; Sarmiento J; Boric MP; Birukov K; Cancino J; Varas-Godoy M; Soza A; Alves NG; Mujica PE; Durán WN; Ehrenfeld P; Sánchez FA
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1083-H1095. PubMed ID: 34652985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCzeta decreases eNOS protein stability via inhibitory phosphorylation of ERK5.
    Nigro P; Abe J; Woo CH; Satoh K; McClain C; O'Dell MR; Lee H; Lim JH; Li JD; Heo KS; Fujiwara K; Berk BC
    Blood; 2010 Sep; 116(11):1971-9. PubMed ID: 20538799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNFα inhibits IGFBP-3 through activation of p38α and casein kinase 2 in human retinal endothelial cells.
    Zhang Q; Soderland D; Steinle JJ
    PLoS One; 2014; 9(7):e103578. PubMed ID: 25073020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epac1 deacetylates HMGB1 through increased IGFBP-3 and SIRT1 levels in the retinal vasculature.
    Jiang Y; Liu L; Steinle JJ
    Mol Vis; 2018; 24():727-732. PubMed ID: 30581279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
    Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDF-1 contributes to the regulation of nitric oxide release in VEGF-treated human endothelial cells.
    Leidi M; Mariotti M; Maier JA
    Eur J Cell Biol; 2010 Sep; 89(9):654-60. PubMed ID: 20605058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HB-EGF-induced VEGF production and eNOS activation depend on both PI3 kinase and MAP kinase in HaCaT cells.
    Nakai K; Yoneda K; Moriue T; Igarashi J; Kosaka H; Kubota Y
    J Dermatol Sci; 2009 Sep; 55(3):170-8. PubMed ID: 19559571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant IGFBP-3 inhibits allergic lung inflammation, VEGF production, and vascular leak in a mouse model of asthma.
    Kim SR; Lee KS; Lee KB; Lee YC
    Allergy; 2012 Jul; 67(7):869-77. PubMed ID: 22563687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells.
    Feliers D; Chen X; Akis N; Choudhury GG; Madaio M; Kasinath BS
    Kidney Int; 2005 Oct; 68(4):1648-59. PubMed ID: 16164642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of endothelial nitric oxide synthase by atypical PKC zeta contributes to angiopoietin-1-dependent inhibition of VEGF-induced endothelial permeability in vitro.
    Oubaha M; Gratton JP
    Blood; 2009 Oct; 114(15):3343-51. PubMed ID: 19564638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.